Activation of the STING pathway has been shown to enhance the efficacy of immune checkpoint blockade.[50] In our study, the activation of the STING pathway via C5‐PE38 was shown to enhance the anti‐tumor immune response, likely by promoting the infiltration of T cells and the overall reprogramming of the TME. Here, STING1 is linked to neoplasm.